(firstQuint)Blinded, Randomized Study of Gabapentin (Neurontin) and Gabapentin Enacarbil (Horizant) in Restless Leg Syndrome.

 The study will compare the safety, effectiveness and tolerability of gabapentin (Neurontin) versus gabapentin enacarbil (Horizant) as treatment restless leg syndrome.

 Subjects will be randomized to gabapentin (IR) or Horizant cent (ER).

 Dosing will be blinded to both patient and study team members.

 Once study medication dosing has been optimized, subjects will then remain on a stable dose for six weeks until study endpoint, after which subjects will be down-titrated off of study medications.

.

 Blinded, Randomized Study of Gabapentin (Neurontin) and Gabapentin Enacarbil (Horizant) in Restless Leg Syndrome@highlight

The study will compare the safety, effectiveness and tolerability of gabapentin (Neurontin) versus gabapentin enacarbil (Horizant) as treatment restless leg syndrome.

